Home https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ Business https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ Operation Warp Speed ​​predicts 100 million Americans immunized against COVID-19 by the end of February

Operation Warp Speed ​​predicts 100 million Americans immunized against COVID-19 by the end of February



This photo, taken on May 23, 2020, shows a laboratory technician holding a dose of candidate for a new vaccine against coronavirus COVID-19. (Photo by MLADEN ANTONOV / AFP via Getty Images)

TO the editorial office
UPDATED 18:30 PT – Wednesday, December 2, 2020

The Trump administration highlighted the continued success of Operation Warp Speed ​​in its latest update in the fight to develop the COVID-19 vaccine.

During a press briefing Wednesday, Chief Operations Adviser Moncef Slavey predicted that at least 100 million Americans would be immunized against the virus by the end of February.

This is because about 20 million people are expected to be vaccinated with Pfizer and Moderna in December alone.

Slavey added that 30 million people will be vaccinated by January and 50 million by February.

Preliminary vaccine participants Pfizer and Moderna have sent their vaccines to the FDA for emergency approval. Each of them has proven its high efficiency of about 95 percent.

Once approved, the Warp Speed ​​team can begin delivering doses within two days of authorization. Chief Operating Officer General Gus Perna said they would release doses when they became available.

“We are not waiting for a group of vaccines to be available and then pushing,” Perna said. “We want a rhythmic, rhythmic delivery of the vaccine so that the states can best manage it according to priorities, as they have developed it.”

Government officials will determine who receives the vaccine first. Advocacy groups called for health workers and the elderly to be examined.

It is also unclear whether the Pfizer and Moderna vaccines will be available after February. However, officials said other companies such as Johnson & Johnson and AstraZeneca were also in the process of producing coronavirus vaccines. They could receive approval early next year.

RELATED: Federal investigators warn of fake COVID-19 vaccine fraud




Source link